Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Objectives: One-fifth of Covid-19 patients suffer a severe course of Covid-19 infection; however, the specific causes remain unclear. Mast cells (MCs) are activated by SARS-CoV-2. Although only recently recognized, MC activation syndrome (MCAS), usually due to acquired MC clonality, is a chronic mul...
Main Authors: | Lawrence B. Afrin, Leonard B. Weinstock, Gerhard J. Molderings |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220307323 |
Similar Items
-
Mast cell activation syndrome: A new outlook
by: N. V. Mikryukova, et al.
Published: (2023-11-01) -
Insights in Anaphylaxis and Clonal Mast Cell Disorders
by: David González-de-Olano, et al.
Published: (2017-07-01) -
Type II mast cells in mast cell leukemia: Uncommon yet clinically significant
by: Constance P. Chen, et al.
Published: (2024-04-01) -
Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis
by: Holger Seidel, et al.
Published: (2021-08-01) -
Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
by: Lawrence B. Afrin, et al.
Published: (2022-01-01)